MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s12915-021-00979-5

Медицинская библиотека · BMC biology · 2021

Neuronal cell-based high-throughput screen for enhancers of mitochondrial function reveals luteolin as a modulator of mitochondria-endoplasmic reticulum coupling.

Naia Luana, Pinho Catarina M, Dentoni Giacomo, Liu Jianping, Leal Nuno Santos, Ferreira Duarte M S, Schreiner Bernadette, Filadi Riccardo, Fão Lígia, Connolly Niamh M C, Forsell Pontus, Nordvall Gunnar, Shimozawa Makoto, Greotti Elisa, Basso Emy, Theurey Pierre, Gioran Anna, Joselin Alvin, Arsenian-Henriksson Marie, Nilsson Per, Rego A Cristina, Ruas Jorge L, Park David, Bano Daniele, Pizzo Paola, Prehn Jochen H M, Ankarcrona Maria

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Mitochondrial dysfunction is a common feature of aging, neurodegeneration, and metabolic diseases. Hence, mitotherapeutics may be valuable disease modifiers for a large number of conditions. In this study, we have set up a large-scale screening platform for mitochondrial-based modulators with promising therapeutic potential.

RESULTS

Using differentiated human neuroblastoma cells, we screened 1200 FDA-approved compounds and identified 61 molecules that significantly increased cellular ATP without any cytotoxic effect. Following dose response curve-dependent selection, we identified the flavonoid luteolin as a primary hit. Further validation in neuronal models indicated that luteolin increased mitochondrial respiration in primary neurons, despite not affecting mitochondrial mass, structure, or mitochondria-derived reactive oxygen species. However, we found that luteolin increased contacts between mitochondria and endoplasmic reticulum (ER), contributing to increased mitochondrial calcium (Ca2+) and Ca2+-dependent pyruvate dehydrogenase activity. This signaling pathway likely contributed to the observed effect of luteolin on enhanced mitochondrial complexes I and II activities. Importantly, we observed that increased mitochondrial functions were dependent on the activity of ER Ca2+-releasing channels inositol 1,4,5-trisphosphate receptors (IP3Rs) both in neurons and in isolated synaptosomes. Additionally, luteolin treatment improved mitochondrial and locomotory activities in primary neurons and Caenorhabditis elegans expressing an expanded polyglutamine tract of the huntingtin protein.

CONCLUSION

We provide a new screening platform for drug discovery validated in vitro and ex vivo. In addition, we describe a novel mechanism through which luteolin modulates mitochondrial activity in neuronal models with potential therapeutic validity for treatment of a variety of human diseases.

Для цитирования: Naia Luana, Pinho Catarina M, Dentoni Giacomo, Liu Jianping, Leal Nuno Santos, Ferreira Duarte M S, Schreiner Bernadette, Filadi Riccardo, Fão Lígia, Connolly Niamh M C, Forsell Pontus, Nordvall Gunnar, Shimozawa Makoto, Greotti Elisa, Basso Emy, Theurey Pierre, Gioran Anna, Joselin Alvin, Arsenian-Henriksson Marie, Nilsson Per, Rego A Cristina, Ruas Jorge L, Park David, Bano Daniele, Pizzo Paola, Prehn Jochen H M, Ankarcrona Maria. Neuronal cell-based high-throughput screen for enhancers of mitochondrial function reveals luteolin as a modulator of mitochondria-endoplasmic reticulum coupling.. BMC biology. 2021. DOI: 10.1186/s12915-021-00979-5.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.